[Asia Economy Reporter Jang Hyowon] Humasis announced on the 22nd that it has signed a contract to supply COVID-19 antigen rapid test kits worth 27.1 billion KRW with 'FIOCRUZ - INSTITUTO DE TECNOLOGIA EM IMUNOBIOLOGICOS.'



This amount corresponds to 59.23% of recent sales revenue. The contract period is until March 31, 2022, and the sales supply region is Brazil.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing